Heart Test Labs Files 8-K on Operations
Ticker: HSCSW · Form: 8-K · Filed: Jul 29, 2024 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heart Test Laboratories, Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-condition, operations
TL;DR
Heart Test Labs filed an 8-K updating investors on financials.
AI Summary
Heart Test Laboratories, Inc. filed an 8-K on July 29, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates that Heart Test Laboratories, Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Heart Test Laboratories, Inc. (company) — Registrant
- July 29, 2024 (date) — Date of earliest event reported
- Texas (location) — State of Incorporation
- 550 Reserve Street, Suite 360 (address) — Principal Executive Offices
- Southlake, Texas 76092 (address) — Principal Executive Offices Location
FAQ
What specific financial results or conditions are being reported by Heart Test Laboratories, Inc. in this 8-K?
The provided text of the 8-K filing does not contain specific details on the financial results or conditions being reported, only that the filing pertains to 'Results of Operations and Financial Condition'.
What is the SIC code for Heart Test Laboratories, Inc. and what does it represent?
The SIC code for Heart Test Laboratories, Inc. is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
When was Heart Test Laboratories, Inc. incorporated and in which state?
Heart Test Laboratories, Inc. was incorporated in Texas.
What is the principal executive office address for Heart Test Laboratories, Inc.?
The principal executive office address is 550 Reserve Street, Suite 360, Southlake, Texas 76092.
What is the Commission File Number for Heart Test Laboratories, Inc.?
The Commission File Number for Heart Test Laboratories, Inc. is 001-41422.
Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-07-29 16:05:09
Filing Documents
- ea0210212-8k_heart.htm (8-K) — 30KB
- ea021021201ex99-1_heart.htm (EX-99.1) — 30KB
- ex99-1_001.jpg (GRAPHIC) — 9KB
- 0001013762-24-002081.txt ( ) — 294KB
- hscs-20240729.xsd (EX-101.SCH) — 3KB
- hscs-20240729_def.xml (EX-101.DEF) — 26KB
- hscs-20240729_lab.xml (EX-101.LAB) — 36KB
- hscs-20240729_pre.xml (EX-101.PRE) — 25KB
- ea0210212-8k_heart_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On July 29, 2024, Heart Test Laboratories, Inc. (the "Company") issued a press release providing information regarding the Company's financial and operating results for its fiscal year ended April 30, 2024, and other business updates. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated by reference herein. The information contained in Item 2.02 of this Current Report and Exhibit 99.1 to this Current Report shall not be deemed to be "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act") , or otherwise subject to the liabilities of that section , nor shall it be deemed incorporated by reference in any filings made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Press Release dated July 29, 2024 104* Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished herewith. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEART TEST LABORATORIES, INC. Date: July 29, 2024 By: /s/ Andrew Simpson Name: Andrew Simpson Title: President, Chief Executive Officer and Chairman of the Board of Directors 2